GridAI Technologies Corp. (GRDX)

GridAI Technologies Corp. (GRDX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $27.2M; returns 1 day +2.1%, 1 week +32.8%.

Entero Therapeutics, Inc. (NASDAQ: GRDX), formerly ENTO, has undergone a strategic transformation, pivoting from a clinical-stage biopharmaceutical company focused on gastrointestinal (GI) diseases to an AI-driven grid-edge technology provider. This shift was marked by the acquisition of GRID AI Corp. and a corporate name change to GridAI Technologies Corp, effective December 1, 2025.

Groups GRDX belongs to

• United Kingdom Companies
• Artificial Intelligence
• AI Infrastructure
• Grid Modernization
• Clean Energy Transition
• Software
• Edge Computing
• Utility Infrastructure
• Climate Resilience
• Decarbonization

GRDX financial model: income statement, cash flow and balance sheet